Showing results (31-40 of 73) with videos related to
Sort By:
Pageof 8
Frontiers in Immunology|February 20, 2025
IFNβ drives ferroptosis through elevating TRIM22 and promotes the cytotoxicity of RSL3Huiyue Dong, Ling Zhu, Jingjing Sun, et al.Frontiers in Oncology|November 16, 2020
The Role of <i>ARL4C</i> in Erlotinib Resistance: Activation of the <i>Jak2</i>/<i>Stat 5</i>/β-<i>Catenin</i> Signaling PathwayJinrong Liao, Zeng Chen, Zongyang Yu, et al.Frontiers in Medicine|July 24, 2023
Comparison of different therapeutic approaches for pulmonary cryptococcosis in kidney transplant recipients: a 15-year retrospective analysisShuyang Chen, Guoqing Yu, Meiyan Chen, et al.Frontiers in Immunology|July 8, 2025
BRICS sequential therapeutic regimen as first-Line treatment for PD-L1-negative metastatic non-small cell lung cancer patients harboring EGFR/ALK wild-type status: a retrospective studyJianxin Chen, Jian Wang, Weiqiang Fang, et al.Life Sciences|November 5, 2019
Icariin induces apoptosis of human lung adenocarcinoma cells by activating the mitochondrial apoptotic pathwayXiaoli Wu, Wencui Kong, Xiaoyan Qi, et al.Journal of Cellular and Molecular Medicine|February 10, 2021
EXT1 methylation promotes proliferation and migration and predicts the clinical outcome of non-small cell lung carcinoma via WNT signalling pathwayWencui Kong, Ying Chen, Zhongquan Zhao, et al.Frontiers in Medicine|May 13, 2025
Isavuconazole as an optimal treatment option for multiple pathogens induced severe pneumonia in immunocompromised hosts: a case series reportXinyin Wang, Yanjing You, Shuyang Chen, et al.Clinical Lung Cancer|March 8, 2020
Association Between RET Fusions and Efficacy of Pemetrexed-based Chemotherapy for Patients With Advanced NSCLC in China: A Multicenter Retrospective StudyTianle Shen, Xingxiang Pu, Liping Wang, et al.ACS Sensors|May 19, 2025
A CRISPR/Cas12a-Assisted SERS Nanosensor for Highly Sensitive Detection of HPV DNAJianqing Ye, Yongshi Shen, Zhizhong Lin, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 15, 2020
The deep learning model combining CT image and clinicopathological information for predicting ALK fusion status and response to ALK-TKI therapy in non-small cell lung cancer patientsZhengbo Song, Tianchi Liu, Lei Shi, et al.Pageof 8